REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Citi Pharma Limited (Pakistan)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Citi Pharma Limited Profile Updated: October 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The Company is engaged in manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
The Company was incorporated as a private limited on October 08, 2012 and latterly converted into public unlisted company on October 13, 2020.
The company was listed on PSX on July 09, 2021.

Headquarters
588-Q Block, Johar Town
Lahore; Punjab;

Contact Details: Purchase the Citi Pharma Limited report to view the information.

Website: http://www.citipharma.com.pk

Basic Information
Total Employees:
Purchase the Citi Pharma Limited report to view the information.
Outstanding Shares:
Purchase the Citi Pharma Limited report to view the information.
Financial Auditors:
Purchase the Citi Pharma Limited report to view the information.
Incorporation Date:
2012
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
33.26%
Purchase this report to view the information.
25.9%
Purchase this report to view the information.
19.5%
Purchase this report to view the information.
6.5%
Purchase this report to view the information.
1.3%
Company Performance
Financial values in the chart are available after Citi Pharma Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PKR. Absolute financial data is included in the purchased report.
Net sales revenue
0.1%▲
Total operating revenue
0.1%▲
Operating profit (EBIT)
0.82%▲
EBITDA
6.82%▲
Net Profit (Loss) for the Period
26.67%▲
Total assets
14.21%▲
Total equity
4.84%▲
Operating Profit Margin (ROS)
0.08%▲
Net Profit Margin
1.41%▲
Return on Equity (ROE)
2.55%▲
Debt to Equity Ratio
-7.3%▼
Quick Ratio
-0.11%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo